SCHEMBL7328433

SCHEMBL7328433

OC1C(S)C2CCN1CC2

nearest known ligand 0.38

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
SLC18A3 Q16572 2/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2300746 0.77
SCHEMBL27816064 0.72 SLC18A3 (0.41) SLC18A3
SCHEMBL5398154 0.72 SLC18A3 (0.41) SLC18A3
SCHEMBL19468663 0.68
SCHEMBL6519582 0.63 SLC18A3 (0.38) SLC18A3
SCHEMBL1404005 0.63 SLC18A3 (0.38) SLC18A3
SCHEMBL20399990 0.61 MAN2B1 (0.39) SLC18A3
SCHEMBL1404038 0.59 SLC18A3 (0.44) SLC18A3
SCHEMBL1648569 0.58
SCHEMBL2801018 0.58 SLC18A3 (0.38) SLC18A3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5194605-A Treatment of hypertension, hyperaldosteronism, congestive heart failure, glaucoma MERCK & CO., INC. (US) 1993-03-16 US disclosed
EP-0518676-A2 Cyclic renin inhibitors MERCK & CO. INC. (US) 1992-12-16 EP disclosed
EP-0432975-A1 Cyclic renin inhibitors MERCK & CO. INC. (US) 1991-06-19 EP disclosed